This inventor holds 2 USPTO granted patents. Top assignee: Vide Pharmaceuticals. Active years: 1997-1999.
Company Filing History:
Years Active: 1997-1999
Title: The Innovations of Charles Bakhit
Introduction
Charles Bakhit is an accomplished inventor based in La Verne, California. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Bakhit has focused on developing methods and compositions that address critical issues related to intraocular pressure.
Latest Patents
Bakhit's latest patents include groundbreaking work on ATP-sensitive K.sup.+ channel inhibition. These patents detail how ATP-sensitive K.sup.+ channel modulating compounds can be incorporated into ophthalmically acceptable carriers for administration to the eye. This innovation aims to affect intraocular pressure, making it particularly suitable for treating glaucoma and other disorders related to elevated intraocular pressure. Additionally, formulations that potentiate the channel are designed to treat hypotonia and other conditions associated with depressed intraocular pressure.
Career Highlights
Charles Bakhit is currently associated with Vide Pharmaceuticals, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment options for patients suffering from various eye conditions.
Collaborations
Bakhit collaborates with Nino Sorgente, contributing to the innovative environment at Vide Pharmaceuticals. Their partnership exemplifies the importance of teamwork in the pursuit of medical advancements.
Conclusion
Charles Bakhit's contributions to ophthalmology through his patents demonstrate his commitment to improving patient care. His innovative approaches to managing intraocular pressure highlight the potential for significant advancements in the treatment of eye disorders.